Raymond James & Associates Decreases Stock Position in TriMas Co. (NASDAQ:TRS)

Raymond James & Associates lessened its position in shares of TriMas Co. (NASDAQ:TRSGet Rating) by 2.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 73,977 shares of the industrial products company’s stock after selling 2,017 shares during the period. Raymond James & Associates owned 0.18% of TriMas worth $1,855,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Strs Ohio grew its stake in TriMas by 6.5% in the 2nd quarter. Strs Ohio now owns 6,600 shares of the industrial products company’s stock valued at $182,000 after buying an additional 400 shares in the last quarter. Pinebridge Investments L.P. lifted its holdings in TriMas by 371.5% during the 2nd quarter. Pinebridge Investments L.P. now owns 943 shares of the industrial products company’s stock worth $26,000 after purchasing an additional 743 shares in the last quarter. Sei Investments Co. boosted its stake in TriMas by 1.0% in the 1st quarter. Sei Investments Co. now owns 175,437 shares of the industrial products company’s stock worth $5,630,000 after purchasing an additional 1,704 shares during the period. PNC Financial Services Group Inc. grew its holdings in TriMas by 182.2% during the 1st quarter. PNC Financial Services Group Inc. now owns 2,912 shares of the industrial products company’s stock valued at $94,000 after buying an additional 1,880 shares in the last quarter. Finally, Citadel Advisors LLC increased its position in shares of TriMas by 17.3% during the second quarter. Citadel Advisors LLC now owns 19,855 shares of the industrial products company’s stock valued at $549,000 after buying an additional 2,927 shares during the period. Institutional investors own 99.94% of the company’s stock.

Insider Buying and Selling

In other news, CEO Thomas A. Amato acquired 5,000 shares of TriMas stock in a transaction dated Friday, October 28th. The shares were purchased at an average cost of $22.37 per share, for a total transaction of $111,850.00. Following the transaction, the chief executive officer now owns 234,550 shares of the company’s stock, valued at $5,246,883.50. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other TriMas news, insider Fabio Leandro Matheus Salik bought 4,300 shares of the firm’s stock in a transaction that occurred on Friday, October 28th. The shares were bought at an average price of $23.45 per share, for a total transaction of $100,835.00. Following the transaction, the insider now directly owns 22,056 shares in the company, valued at $517,213.20. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Thomas A. Amato purchased 5,000 shares of the stock in a transaction on Friday, October 28th. The stock was acquired at an average cost of $22.37 per share, with a total value of $111,850.00. Following the completion of the purchase, the chief executive officer now directly owns 234,550 shares of the company’s stock, valued at $5,246,883.50. The disclosure for this purchase can be found here. Over the last ninety days, insiders purchased 9,324 shares of company stock worth $213,320. Corporate insiders own 1.10% of the company’s stock.

TriMas Stock Performance

Shares of TRS opened at $29.61 on Tuesday. TriMas Co. has a 12-month low of $21.41 and a 12-month high of $35.37. The company has a current ratio of 2.63, a quick ratio of 1.53 and a debt-to-equity ratio of 0.62. The company has a market cap of $1.24 billion, a PE ratio of 20.85 and a beta of 0.69. The stock has a 50-day moving average price of $27.90 and a 200-day moving average price of $27.37.

TriMas (NASDAQ:TRSGet Rating) last announced its earnings results on Thursday, October 27th. The industrial products company reported $0.40 earnings per share for the quarter, missing analysts’ consensus estimates of $0.61 by ($0.21). TriMas had a net margin of 6.76% and a return on equity of 11.55%. The company had revenue of $218.53 million during the quarter, compared to analysts’ expectations of $246.69 million. As a group, equities analysts forecast that TriMas Co. will post 2.15 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts recently commented on TRS shares. William Blair cut shares of TriMas from an “outperform” rating to a “market perform” rating in a research note on Friday, October 28th. StockNews.com lowered shares of TriMas from a “buy” rating to a “hold” rating in a research report on Thursday, October 20th.

TriMas Profile

(Get Rating)

TriMas Corporation designs, develops, manufactures, and sells products for consumer products, aerospace, and industrial markets worldwide. It operates through three segments: Packaging, Aerospace, and Specialty Products. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, flexible spouts, and agricultural closures; polymeric jar products; integrated dispensers; bag-in-box products; aseptic closures; industrial closures and flex spouts; custom injection molded components and devices; various injection molded products; and single-bodied and assembled caps and closures under the Rieke, Taplast, Affaba & Ferrari, Stolz, Omega, and Rapak brands.

Featured Articles

Institutional Ownership by Quarter for TriMas (NASDAQ:TRS)

Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.